Syncor aids in Israeli radiopharmacy project
This article was originally published in Clinica
Executive Summary
Syncor's international subsidiary, Syncor Overseas, has entered into an agreement with the Israeli government to license Syncor's proprietary technology to establish a radiopharmacy in Israel. Israel's Soreq Research and Development Institute along with its commercial offshoot, Isorad, will receive operational and management advice, technical and purchasing assistance, as well as proprietary knowledge developed by Syncor.